查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029年全球肾脏生物标志物市场规模研究与预测，按生物标志物类型、诊断技术（、终端用户和区域分析）分类
市场调查报告书
商品编码
1269705

2022-2029年全球肾脏生物标志物市场规模研究与预测，按生物标志物类型、诊断技术（、终端用户和区域分析）分类

Global Renal Biomarkers Market Size study & Forecast, by Biomarker type by Diagnostic Technique (, by End User and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

生物标志物是生物体的一种生物特征，被评估为典型生物功能的标志。肾脏生物标志物是识别急性和慢性肾脏损伤以及其他一些肾脏疾病的重要诊断工具。肾脏疾病的治疗主要是利用肾脏生物标志物。这些生物标志物在研究和临床方面都有帮助，用于分析肾脏系统的功能。肾脏生物标志物市场正在扩大，因为各种肾脏相关疾病的发病率不断增加，以及慢性肾脏疾病的进展速度不断提高等因素。

2022年4月的一篇肾脏国际补充剂文章称，全世界每年有数百万人死于慢性肾脏疾病，这影响到世界人口的10%左右。慢性肾脏病人正变得越来越普遍。另外，与西方国家相比，亚洲国家与糖尿病相关的慢性肾脏疾病的发病率明显更高。例如，根据国际糖尿病联合会2021年的一份报告，印度在2021年估计有74,194.7万例糖尿病，到2030年，这一数字预计将上升到92,973.7万例。因此，预计在预测期内，由于肾脏疾病及其相关原因的发病率上升，对肾脏疾病诊断的需求将上升。这将推动生物标志物的发展。此外，市场参与者在遗传技术领域的进步和产品开发的战略活动正在创造有利可图的市场增长。然而，肾脏生物标志物的高成本可能会阻止市场增长。

全球肾脏生物标志物市场研究的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于品牌产品的主导地位和该地区日益增长的疾病流行率，北美在收入方面主导了市场。而亚太地区在预测期内预计将以最高的复合年增长率增长，原因是老年病和目标人群的增加，产品开发合作的数量增加，主要参与者的地理扩张，以及政府和非营利组织对市场空间的积极参与等因素。

该研究的目的是确定近年来不同领域和国家的市场规模，并对未来几年的价值进行预测。该报告旨在将研究涉及的国家内的行业的质量和数量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还包括微观市场的潜在机会，供利益相关者投资，以及对竞争格局和主要参与者的生物标志物类型的详细分析。.

目录

第一章：执行摘要

  • 市场简介
  • 2019-2029年全球和细分市场的估计和预测
    • 2019-2029年，按地区分類的肾脏生物标志物市场
    • 肾脏生物标志物市场，按生物标志物类型，2019-2029年
    • 2019-2029年肾脏生物标志物市场，按诊断技术划分
    • 2019-2029年肾脏生物标志物市场，按终端用户划分
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球肾脏生物标志物市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 研究的范围
    • 行业演变
  • 研究考虑的年份
  • 货币兑换率

第三章：全球肾脏生物标志物市场动态

  • 肾脏生物标志物市场影响分析（2019-2029年）
    • 市场驱动力
      • 各种肾脏相关疾病的发病率不断增加、
      • 慢性肾脏疾病的进展率不断上升
    • 市场挑战
      • 肾脏生物标志物的高成本
    • 市场机会
      • 遗传技术领域的进步
      • 市场参与者开发产品的战略活动

第四章：全球肾脏生物标志物市场行业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力模型的未来方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 经济
    • 社会
    • 技术
  • 最佳投资机会
  • 最佳策略
  • 行业专家展望
  • 分析师建议和结论

第五章：风险评估：COVID-19的影响

  • 评估COVID-19对行业的整体影响
  • COVID-19前和COVID-19后的市场情况

第六章：全球肾脏生物标志物市场，按生物标志物类型划分

  • 市场简介
  • 全球肾脏生物标志物市场，按生物标志物类型，性能-潜力分析
  • 2019-2029年全球肾脏生物标志物市场按生物标志物类型估计和预测的情况
  • 肾脏生物标志物市场，細項分析
    • 功能性生物标志物
    • 上调的蛋白质
    • 其他生物标志物类型

第7章 ：全球肾脏生物标志物市场，按诊断技术分类

  • 市场简介
  • 按诊断技术分类的全球肾脏生物标志物市场，表现 - 潜力分析
  • 2019-2029年全球肾脏生物标志物市场按诊断技术的估计和预测
  • 肾脏生物标志物市场，細項分析
    • 酶联免疫吸附分析法
    • 颗粒增强浊度免疫分析法（PETIA)
    • 比色法
    • 化学发光酶联免疫分析法（CLIA）
    • 液相色谱-质谱法（LS-MS）。

第八章：全球肾脏生物标志物市场，按终端用户分类

  • 市场简介
  • 按终端用户分類的全球肾脏生物标志物市场，性能-潜力分析
  • 2019-2029年全球肾脏生物标志物市场按终端用户估计和预测的情况
  • 肾脏生物标志物市场，細項分析
    • 医院
    • 诊断实验室
    • 其他终端用户

第九章：全球肾脏生物标志物市场，区域分析

  • 肾脏生物标志物市场，区域市场简介
  • 北美洲
    • 美国
      • 2019-2029年，生物标志物类型的细分估计和预测
      • 诊断技术分类估计和预测，2019-2029年
      • 2019-2029年终端用户分类估计和预测
    • 加拿大
  • 欧洲肾脏生物标志物市场简介
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区肾脏生物标志物市场简况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉美肾脏生物标志物市场简介
    • 巴西
    • 墨西哥
    • 拉美其他地区
  • 世界其他地区

第十章：竞争情报

  • 顶级市场战略
  • 公司简介
    • Abbott Laboratories
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • BioPorto Diagnostics AS
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Nexelis (Pacific Biomarkers)
    • BioMerieux
    • Sphingotec GmbH
    • Randox Laboratories Ltd
    • Siemens Healthineers AG
    • Enzo Life Sciences, Inc.

第十一章 ：研究过程

  • 研究过程
    • 资料探勘
    • 数据分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Renal Biomarkers Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. A biomarker is a biological characteristic of an organism that is assessed as a sign of typical biological function. Renal biomarkers are a crucial diagnostic tool for identifying both acute and chronic kidney injury as well as several other kidney disorders. Renal disorders are primarily treated using renal biomarkers. These biomarkers are helpful in both research and clinical contexts and are used to analyze the renal system's functionality. The Renal Biomarkers Market is expanding because of factors such as the increasing incidence of various kidney-related diseases, and the increasing rate of progression of chronic kidney disease.

A Kidney International Supplements article from April 2022 claims that millions of people worldwide pass away each year from chronic kidney disease, which affects about 10% of the world's population. Chronic renal disease individuals are becoming more prevalent. Also, compared to Western nations, Asian nations had a significantly higher incidence of diabetes-related chronic renal illnesses. For instance, according to a 2021 report from the International Diabetes Federation, India had an estimated 74,194.7 thousand cases of diabetes in 2021, and by 2030, that number is predicted to rise to 92,973.7 thousand cases. Thus, it is anticipated that over the projection period, demand for renal disease diagnosis would rise in response to the rising prevalence of kidney illnesses and their associated causes. This will fuel the development of biomarkers. Furthermore, advancements in the field of genetic technology strategic activities by market players for product development are creating lucrative growth in the market. However, the high cost of renal biomarkers may halt market growth.

The key regions considered for the Global Renal Biomarkers Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

  • Abbott Laboratories
  • BioPorto Diagnostics AS
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Nexelis (Pacific Biomarkers)
  • BioMerieux
  • Sphingotec GmbH
  • Randox Laboratories Ltd
  • Siemens Healthineers AG
  • Enzo Life Sciences, Inc.

Recent Developments in the Market:

  • In December 2022, the company Journey Biosciences, Inc. has announced the release of NaviDKD, its flagship product, a blood test based on biomarkers that forecast long-term kidney issues in diabetics. The only screening method that gives diabetics a head starts on the risk of developing kidney disease.
  • In March 2022, Renalytix plc has announced the launch of myIntelX, a new provider access portal that will enable doctors to order KidneyIntelX prognostic (blood-based biomarker) testing online for more accurate identification of patients at the highest risk of rapid progression of kidney disease in type 2 diabetes.

Global Renal Biomarkers Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Biomarker type, Diagnostic Technique, End User, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Biomarker typeofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Biomarker Type:

  • Functional Biomarker
  • Up-regulated Protein
  • Other Biomarker Types

By Diagnostic Technique:

  • Enzyme-linked Immunosorbent Assay
  • Particle-enhanced Turbidimetric Immunoassay (PETIA)
  • Colorimetric Assay
  • Chemiluminescent Enzyme Immunoassay (CLIA)
  • Liquid Chromatography-mass Spectrometry (LS-MS)

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Other End Users

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Renal Biomarkers Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Renal Biomarkers Market, by Biomarker Type, 2019-2029 (USD Billion)
    • 1.2.3. Renal Biomarkers Market, by Diagnostic Technique, 2019-2029 (USD Billion)
    • 1.2.4. Renal Biomarkers Market, by End User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Renal Biomarkers Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Renal Biomarkers Market Dynamics

  • 3.1. Renal Biomarkers Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of various kidney-related diseases,
      • 3.1.1.2. increasing rate of progression of chronic kidney disease
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Renal Biomarkers
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in the field of genetic technology
      • 3.1.3.2. Strategic activities by market players for product development

Chapter 4. Global Renal Biomarkers Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Renal Biomarkers Market, by Biomarker Type

  • 6.1. Market Snapshot
  • 6.2. Global Renal Biomarkers Market by Biomarker Type, Performance - Potential Analysis
  • 6.3. Global Renal Biomarkers Market Estimates & Forecasts by Biomarker Type 2019-2029 (USD Billion)
  • 6.4. Renal Biomarkers Market, Sub Segment Analysis
    • 6.4.1. Functional Biomarker
    • 6.4.2. Up-regulated Protein
    • 6.4.3. Other Biomarker Types

Chapter 7. Global Renal Biomarkers Market, by Diagnostic Technique

  • 7.1. Market Snapshot
  • 7.2. Global Renal Biomarkers Market by Diagnostic Technique, Performance - Potential Analysis
  • 7.3. Global Renal Biomarkers Market Estimates & Forecasts by Diagnostic Technique 2019-2029 (USD Billion)
  • 7.4. Renal Biomarkers Market, Sub Segment Analysis
    • 7.4.1. Enzyme-linked Immunosorbent Assay
    • 7.4.2. Particle-enhanced Turbidimetric Immunoassay (PETIA)
    • 7.4.3. Colorimetric Assay
    • 7.4.4. Chemiluminescent Enzyme Immunoassay (CLIA)
    • 7.4.5. Liquid Chromatography-mass Spectrometry (LS-MS)

Chapter 8. Global Renal Biomarkers Market, by End User

  • 8.1. Market Snapshot
  • 8.2. Global Renal Biomarkers Market by End User, Performance - Potential Analysis
  • 8.3. Global Renal Biomarkers Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
  • 8.4. Renal Biomarkers Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Diagnostic Laboratories
    • 8.4.3. Other End Users

Chapter 9. Global Renal Biomarkers Market, Regional Analysis

  • 9.1. Renal Biomarkers Market, Regional Market Snapshot
  • 9.2. North America Renal Biomarkers Market
    • 9.2.1. U.S. Renal Biomarkers Market
      • 9.2.1.1. Biomarker Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Diagnostic Technique breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Renal Biomarkers Market
  • 9.3. Europe Renal Biomarkers Market Snapshot
    • 9.3.1. U.K. Renal Biomarkers Market
    • 9.3.2. Germany Renal Biomarkers Market
    • 9.3.3. France Renal Biomarkers Market
    • 9.3.4. Spain Renal Biomarkers Market
    • 9.3.5. Italy Renal Biomarkers Market
    • 9.3.6. Rest of Europe Renal Biomarkers Market
  • 9.4. Asia-Pacific Renal Biomarkers Market Snapshot
    • 9.4.1. China Renal Biomarkers Market
    • 9.4.2. India Renal Biomarkers Market
    • 9.4.3. Japan Renal Biomarkers Market
    • 9.4.4. Australia Renal Biomarkers Market
    • 9.4.5. South Korea Renal Biomarkers Market
    • 9.4.6. Rest of Asia Pacific Renal Biomarkers Market
  • 9.5. Latin America Renal Biomarkers Market Snapshot
    • 9.5.1. Brazil Renal Biomarkers Market
    • 9.5.2. Mexico Renal Biomarkers Market
    • 9.5.3. Rest of Latin America Renal Biomarkers Market
  • 9.6. Rest of The World Renal Biomarkers Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. BioPorto Diagnostics AS
    • 10.2.3. F. Hoffmann-La Roche AG
    • 10.2.4. Thermo Fisher Scientific Inc.
    • 10.2.5. Nexelis (Pacific Biomarkers)
    • 10.2.6. BioMerieux
    • 10.2.7. Sphingotec GmbH
    • 10.2.8. Randox Laboratories Ltd
    • 10.2.9. Siemens Healthineers AG
    • 10.2.10. Enzo Life Sciences, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Renal Biomarkers Market, report scope
  • TABLE 2. Global Renal Biomarkers Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Renal Biomarkers Market estimates & forecasts by Biomarker Type 2019-2029 (USD Billion)
  • TABLE 4. Global Renal Biomarkers Market estimates & forecasts by Diagnostic Technique 2019-2029 (USD Billion)
  • TABLE 5. Global Renal Biomarkers Market estimates & forecasts by End User 2019-2029 (USD Billion)
  • TABLE 6. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Renal Biomarkers Market
  • TABLE 71. List of primary sources, used in the study of global Renal Biomarkers Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Renal Biomarkers Market, research methodology
  • FIG 2. Global Renal Biomarkers Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Renal Biomarkers Market, key trends 2021
  • FIG 5. Global Renal Biomarkers Market, growth prospects 2022-2029
  • FIG 6. Global Renal Biomarkers Market, porters 5 force model
  • FIG 7. Global Renal Biomarkers Market, pest analysis
  • FIG 8. Global Renal Biomarkers Market, value chain analysis
  • FIG 9. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Renal Biomarkers Market, regional snapshot 2019 & 2029
  • FIG 15. North America Renal Biomarkers Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Renal Biomarkers Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Renal Biomarkers Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Renal Biomarkers Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Renal Biomarkers Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable